Veracyte (VCYT) Preferred Stock Liabilities (2012)

Veracyte (VCYT) posted quarterly Preferred Stock Liabilities of $63.4 million for Q4 2012.

Veracyte (VCYT) Preferred Stock Liabilities (2012) Analysis & Trends

Veracyte has reported Preferred Stock Liabilities for 1 years, with the latest figure at $63.4 million in Q4 2012.

Preferred Stock Liabilities for Q4 2012 came in at $63.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2012 was $63.4 million (changed N/A YoY), and the FY2012 annual result was $63.4 million, up 28.55% from the prior year.
Preferred Stock Liabilities steadied at $63.4 million in Q4 2012.
Over five years, Preferred Stock Liabilities peaked at $63.4 million in Q4 2012 and troughed at $63.4 million in Q4 2012.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	-
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	-
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	-
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	-
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	-
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	-
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	-
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	-
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	-
10	Veracyte	3.69 Bn	3.39 Bn	108.55 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2012	63.37 Mn